Clal Biotechnology | CBI - Current Assets


Clal Biotechnology reported ILS14.69M in Current Assets for its fiscal quarter ending in December of 2023.





Current Assets Change Date
Arca Biopharma USD 355.16M 23.15M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Bio Path USD 680K 1.44M Jun/2025
Brainstorm Cell Therapeutics USD 508K 1.01M Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 88.92M 8.72M Sep/2025
Immunic USD 39.27M 20.57M Sep/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 13.02M 2.53M Sep/2025
RedHill Biopharma USD 12.56M 644K Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024